160 related articles for article (PubMed ID: 31231686)
1. Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth.
Kshattry S; Saha A; Gries P; Tiziani S; Stone E; Georgiou G; DiGiovanni J
NPJ Precis Oncol; 2019; 3():16. PubMed ID: 31231686
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer.
Saha A; Zhao S; Chen Z; Georgiou G; Stone E; Kidane D; DiGiovanni J
Mol Ther; 2021 Feb; 29(2):775-787. PubMed ID: 33091613
[TBL] [Abstract][Full Text] [Related]
3. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.
Cramer SL; Saha A; Liu J; Tadi S; Tiziani S; Yan W; Triplett K; Lamb C; Alters SE; Rowlinson S; Zhang YJ; Keating MJ; Huang P; DiGiovanni J; Georgiou G; Stone E
Nat Med; 2017 Jan; 23(1):120-127. PubMed ID: 27869804
[TBL] [Abstract][Full Text] [Related]
4. Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition.
Saha A; Zhao S; Kindall A; Wilder C; Friedman CA; Clark R; Georgiou G; Stone E; Kidane D; DiGiovanni J
J Exp Clin Cancer Res; 2023 May; 42(1):119. PubMed ID: 37170264
[TBL] [Abstract][Full Text] [Related]
5. Cyst(e)inase-Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer.
Kerimoglu B; Lamb C; McPherson RD; Ergen E; Stone EM; Ooi A
Mol Cancer Ther; 2022 Mar; 21(3):419-426. PubMed ID: 35086957
[TBL] [Abstract][Full Text] [Related]
6. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
Habermann KJ; Grünewald L; van Wijk S; Fulda S
Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
[TBL] [Abstract][Full Text] [Related]
7. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
[TBL] [Abstract][Full Text] [Related]
9. SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer.
Lee J; Roh JL
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552652
[TBL] [Abstract][Full Text] [Related]
10. Tissue glutathione as a cyst(e)ine reservoir during cystine depletion in growing rats.
Cho ES; Johnson N; Snider BC
J Nutr; 1984 Oct; 114(10):1853-62. PubMed ID: 6481481
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
12. Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer.
Fazzari F; Chow S; Cheung M; Barghout SH; Schimmer AD; Chang Q; Hedley D
ACS Pharmacol Transl Sci; 2022 Nov; 5(11):1070-1078. PubMed ID: 36407947
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
[TBL] [Abstract][Full Text] [Related]
14. Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion.
You BR; Shin HR; Han BR; Kim SH; Park WH
Mol Med Rep; 2015 Feb; 11(2):1428-34. PubMed ID: 25370167
[TBL] [Abstract][Full Text] [Related]
15. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion.
You BR; Park WH
Oncol Rep; 2016 Jan; 35(1):546-51. PubMed ID: 26530353
[TBL] [Abstract][Full Text] [Related]
16. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
[TBL] [Abstract][Full Text] [Related]
17. Differential redox sensitivity of cathepsin B and L holds the key to autophagy-apoptosis interplay after Thioredoxin reductase inhibition in nutritionally stressed SH-SY5Y cells.
Nagakannan P; Eftekharpour E
Free Radic Biol Med; 2017 Jul; 108():819-831. PubMed ID: 28478025
[TBL] [Abstract][Full Text] [Related]
18. Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells.
Noda T; Iwakiri R; Fujimoto K; Rhoads CA; Aw TY
Cell Prolif; 2002 Apr; 35(2):117-29. PubMed ID: 11952646
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
[TBL] [Abstract][Full Text] [Related]
20. Spatio-temporal changes in glutathione and thioredoxin redox couples during ionizing radiation-induced oxidative stress regulate tumor radio-resistance.
Patwardhan RS; Sharma D; Checker R; Thoh M; Sandur SK
Free Radic Res; 2015 Oct; 49(10):1218-32. PubMed ID: 26021764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
